Schonfeld SJ et al (2021) Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors. Br J Cancer 124(7):1312–1319

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lohmann DR, Gallie BL (1993) Retinoblastoma. In: Adam MP et al (eds) GeneReviews((R)). University of Washington, Seattle

Google Scholar 

Kleinerman RA et al (2019) Patterns of cause-specific mortality among 2053 survivors of retinoblastoma, 1914–2016. J Natl Cancer Inst 111(9):961–969

Article  PubMed  PubMed Central  Google Scholar 

Lohmann D (2010) Retinoblastoma. Adv Exp Med Biol 685:220–227

Article  CAS  PubMed  Google Scholar 

Mohney BG et al (1998) Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol 126(2):269–277

Article  CAS  PubMed  Google Scholar 

Fabius AWM et al (2021) Subsequent malignant neoplasms in retinoblastoma survivors. Cancers 13(6):1200

Article  PubMed  PubMed Central  Google Scholar 

Figueiredo D et al (2023) Risk of second tumors in retinoblastoma survivors after ionizing radiation: a review. Cancers 15(22):5336

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park W, Chawla A, O’Reilly EM (2021) Pancreatic cancer: a review. JAMA 326(9):851–862

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ying H et al (2016) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 30(4):355–385

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kryklyva V et al (2025) Germline pathogenic variants in patients with pancreatic ductal adenocarcinoma and extra-pancreatic malignancies: a nationwide database analysis. Mod Pathol 38(5):100709

Article  PubMed  Google Scholar 

Pantaleo A et al (2023) Understanding the genetic landscape of pancreatic ductal adenocarcinoma to support personalized medicine: a systematic review. Cancers 16(1):56

Article  PubMed  PubMed Central  Google Scholar 

Chen X et al (2023) Risk of syndrome-associated cancers among first-degree relatives of patients with pancreatic ductal adenocarcinoma with pathogenic or likely pathogenic germline variants. JAMA Oncol 9(7):955–961

Article  PubMed  PubMed Central  Google Scholar 

Olakowski M, Buldak L (2022) Current status of inherited pancreatic cancer. Hered Cancer Clin Pract 20(1):26

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klatte DCF et al (2024) Pancreatic cancer surveillance: risk stratification of individuals with a germline CDKN2A pathogenic variant. United Eur Gastroenterol J 12(10):1399–1403

Article  CAS  Google Scholar 

Cowan RW, Maitra A (2014) Genetic progression of pancreatic cancer. Cancer J 20(1):80–84

Article  CAS  PubMed  Google Scholar 

Witkiewicz AK et al (2015) Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun 6:6744

Article  CAS  PubMed  Google Scholar 

Witkiewicz AK et al (2011) The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle 10(15):2497–2503

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knudsen ES et al (2020) Pan-cancer molecular analysis of the RB tumor suppressor pathway. Commun Biol 3(1):158

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chou A et al (2017) Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. Gut 62:2147

Google Scholar 

Witkiewicz AK et al (2023) Determinants of response to CDK4/6 inhibitors in the real-world setting. NPJ Precis Oncol 7(1):90

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiman KG (1993) The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J 7(10):841–845

Article  CAS  PubMed  Google Scholar 

Harbour JW et al (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98(6):859–869

Article  CAS  PubMed  Google Scholar 

Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130(8):1715–1725

Article  CAS  PubMed  Google Scholar 

Xing F et al (2012) Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene 31(4):446–457

Article  CAS  PubMed  Google Scholar 

Papaxoinis G et al (2022) Comparative study of Rb1, cyclin D1 and p16 immunohistochemistry expression to distinguish lung small-cell carcinoma and large-cell neuroendocrine carcinoma. Histopathology 81(2):205–214

Article  CAS  PubMed  Google Scholar